UniProt ID | PAK2_RAT | |
---|---|---|
UniProt AC | Q64303 | |
Protein Name | Serine/threonine-protein kinase PAK 2 | |
Gene Name | Pak2 | |
Organism | Rattus norvegicus (Rat). | |
Sequence Length | 524 | |
Subcellular Localization |
Serine/threonine-protein kinase PAK 2: Cytoplasm. MYO18A mediates the cellular distribution of the PAK2-ARHGEF7-GIT1 complex to the inner surface of the cell membrane.. PAK-2p34: Nucleus. Cytoplasm, perinuclear region. Membrane Lipid-anchor. I |
|
Protein Description | Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation. Acts as downstream effector of the small GTPases CDC42 and RAC1. Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Full-length PAK2 stimulates cell survival and cell growth. Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration. Phosphorylates JUN and plays an important role in EGF-induced cell proliferation. Phosphorylates many other substrates including histone H4 to promote assembly of H3.3 and H4 into nucleosomes, BAD, ribosomal protein S6, or MBP. Additionally, associates with ARHGEF7 and GIT1 to perform kinase-independent functions such as spindle orientation control during mitosis. On the other hand, apoptotic stimuli such as DNA damage lead to caspase-mediated cleavage of PAK2, generating PAK-2p34, an active p34 fragment that translocates to the nucleus and promotes cellular apoptosis involving the JNK signaling pathway. Caspase-activated PAK2 phosphorylates MKNK1 and reduces cellular translation (By similarity).. | |
Protein Sequence | MSDNGELEDKPPAPPVRMSSTIFSTGGKDPLSANHSLKPLPSVPEEKKPRNKIISIFSSTEKGSKKKEKERPEISPPSDFEHTIHVGFDAVTGEFTGMPEQWARLLQTSNITKLEQKKNPQAVLDVLKFYDSNTVKQKYLSFTPPEKDGFPSGTPALNTKGSETSAVVTEEDDDDEDAAPPVIAPRPDHTKSIYTRSVIDPIPAPVGDSNVDSGAKSSDKQKKKAKMTDEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTATDVALGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSYLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMEGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLILAAKEAMKSNR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSDNGELED ------CCCCCCCCC | 39.52 | - | |
2 | Phosphorylation | ------MSDNGELED ------CCCCCCCCC | 39.52 | 27097102 | |
19 | Phosphorylation | PAPPVRMSSTIFSTG CCCCCEEECEEEECC | 17.48 | 28432305 | |
20 | Phosphorylation | APPVRMSSTIFSTGG CCCCEEECEEEECCC | 19.04 | 27097102 | |
21 | Phosphorylation | PPVRMSSTIFSTGGK CCCEEECEEEECCCC | 20.80 | 28432305 | |
24 | Phosphorylation | RMSSTIFSTGGKDPL EEECEEEECCCCCCC | 23.45 | 30181290 | |
25 | Phosphorylation | MSSTIFSTGGKDPLS EECEEEECCCCCCCC | 38.92 | 30181290 | |
38 | Acetylation | LSANHSLKPLPSVPE CCCCCCCCCCCCCCC | 47.74 | 22902405 | |
55 | Phosphorylation | KPRNKIISIFSSTEK CCCCCEEECCCCCCC | 22.51 | 22108457 | |
58 | Phosphorylation | NKIISIFSSTEKGSK CCEEECCCCCCCCCC | 34.38 | 27097102 | |
59 | Phosphorylation | KIISIFSSTEKGSKK CEEECCCCCCCCCCC | 29.81 | 27097102 | |
60 | Phosphorylation | IISIFSSTEKGSKKK EEECCCCCCCCCCCC | 40.28 | 27097102 | |
62 | Acetylation | SIFSSTEKGSKKKEK ECCCCCCCCCCCCCC | 69.44 | - | |
64 | Phosphorylation | FSSTEKGSKKKEKER CCCCCCCCCCCCCCC | 52.98 | 28432305 | |
128 | Acetylation | QAVLDVLKFYDSNTV HHHHHHHHHCCCCCC | 41.55 | - | |
130 | Phosphorylation | VLDVLKFYDSNTVKQ HHHHHHHCCCCCCEE | 19.51 | 22673903 | |
132 | Phosphorylation | DVLKFYDSNTVKQKY HHHHHCCCCCCEEEE | 24.03 | 29779826 | |
134 | Phosphorylation | LKFYDSNTVKQKYLS HHHCCCCCCEEEEEC | 32.79 | 30417516 | |
139 | Phosphorylation | SNTVKQKYLSFTPPE CCCCEEEEECCCCCC | 12.70 | 27097102 | |
141 | Phosphorylation | TVKQKYLSFTPPEKD CCEEEEECCCCCCCC | 24.80 | 28689409 | |
143 | Phosphorylation | KQKYLSFTPPEKDGF EEEEECCCCCCCCCC | 34.26 | 28689409 | |
152 | Phosphorylation | PEKDGFPSGTPALNT CCCCCCCCCCCCCCC | 53.70 | 29779826 | |
154 | Phosphorylation | KDGFPSGTPALNTKG CCCCCCCCCCCCCCC | 15.10 | 27097102 | |
159 | Phosphorylation | SGTPALNTKGSETSA CCCCCCCCCCCCCEE | 37.32 | 27097102 | |
162 | Phosphorylation | PALNTKGSETSAVVT CCCCCCCCCCEEEEE | 38.98 | 27097102 | |
164 | Phosphorylation | LNTKGSETSAVVTEE CCCCCCCCEEEEECC | 24.55 | 27097102 | |
165 | Phosphorylation | NTKGSETSAVVTEED CCCCCCCEEEEECCC | 18.27 | 27097102 | |
169 | Phosphorylation | SETSAVVTEEDDDDE CCCEEEEECCCCCCC | 27.36 | 27097102 | |
192 | Phosphorylation | PRPDHTKSIYTRSVI CCCCCCCCCCCCCCC | 23.22 | 23984901 | |
194 | Phosphorylation | PDHTKSIYTRSVIDP CCCCCCCCCCCCCCC | 11.82 | 23984901 | |
195 | Phosphorylation | DHTKSIYTRSVIDPI CCCCCCCCCCCCCCC | 18.13 | 23984901 | |
197 | Phosphorylation | TKSIYTRSVIDPIPA CCCCCCCCCCCCCCC | 18.67 | 28689409 | |
209 | Phosphorylation | IPAPVGDSNVDSGAK CCCCCCCCCCCCCCC | 32.59 | 22108457 | |
213 | Phosphorylation | VGDSNVDSGAKSSDK CCCCCCCCCCCCCHH | 36.05 | 28689409 | |
217 | Phosphorylation | NVDSGAKSSDKQKKK CCCCCCCCCHHHHHH | 43.14 | 25575281 | |
218 | Phosphorylation | VDSGAKSSDKQKKKA CCCCCCCCHHHHHHC | 48.39 | 28689409 | |
226 | Acetylation | DKQKKKAKMTDEEIM HHHHHHCCCCHHHHH | 51.73 | 22902405 | |
241 | Phosphorylation | EKLRTIVSIGDPKKK HHHHHHHCCCCCCCC | 19.60 | 23984901 | |
370 | Ubiquitination | QVIHRDIKSDNVLLG CCEECCCCCCCEEEC | 56.92 | - | |
401 | Phosphorylation | TPEQSKRSTMVGTPY CHHHHCCCCCCCCCC | 25.29 | 21738781 | |
402 | Phosphorylation | PEQSKRSTMVGTPYW HHHHCCCCCCCCCCC | 21.65 | 22669945 | |
474 | Methylation | EKLSPIFRDFLNRCL HHCCHHHHHHHHHHH | 34.19 | 18962139 | |
479 | Methylation | IFRDFLNRCLEMDVE HHHHHHHHHHHCCHH | 28.66 | 26494511 | |
488 | Methylation | LEMDVEKRGSAKELL HHCCHHHCCCHHHHH | 30.69 | 26494517 | |
507 | Phosphorylation | LKLAKPLSSLTPLIL HHHHHCHHHHHHHHH | 31.65 | 23984901 | |
508 | Phosphorylation | KLAKPLSSLTPLILA HHHHCHHHHHHHHHH | 43.90 | 23984901 | |
510 | Phosphorylation | AKPLSSLTPLILAAK HHCHHHHHHHHHHHH | 20.28 | 23984901 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PAK2_RAT !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
402 | T | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PAK2_RAT !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomics of vasopressin-sensitive renal cells:regulation of aquaporin-2 phosphorylation at two sites."; Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.; Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-139; SER-141 ANDTHR-143, AND MASS SPECTROMETRY. | |
"Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS."; Moser K., White F.M.; J. Proteome Res. 5:98-104(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141, AND MASSSPECTROMETRY. |